| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.02 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.066 | 0.02 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.063 | 0.03 |